Clinical trials with recombinant allergens--a regulatory perspective.
Elferink
André F A
AF
RIVM, BMT, BA, Bilthoven.
D000485:Allergens / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000331:legislation & jurisprudence*; D003888:Desensitization, Immunologic; D005062:European Union; D033161:Government Regulation; D006801:Humans; D011994:Recombinant Proteins / Q000276:immunology* / Q000592:standards / Q000627:therapeutic use*
D000485:Allergens; D011994:Recombinant Proteins